HH
Therapeutic Areas
E-Star BioTech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MANP | Essential Hypertension (First-in-Human) | Phase 1 |
| MANP Platform | Unspecified R&D Program 1 | R&D |
Leadership Team at E-Star BioTech
JC
Jesse Crowne
Chief Executive Officer
SR
Seetha R Iyer
Vice President of Operations
DS
David Smith
Clinical Operations and Medical Safety
LO
Leslie O’Toole
Clinical Operations
EJ
Elizabeth John
Head of CMC and Regulatory
JZ
John Zhihua Zhang
Head of Toxicology
LG
Lucia Gonzalez
Chief Financial Officer
LH
Laura Hsu
Legal Counsel
WM
Whitney McMullin
Executive Admin
EA
Enrique Ampudia
Financial Analyst